关于阿尔茨海默病病理生理学的综述
Uma Agarwal1,2, Garima Kapoor3, Rajiv Kumar Tonk1
1Department of Pharmaceutical Chemistry, Delhi Pharmaceutical Sciences & Research University, Delhi, 110017, India.
Current protein & peptide science
|October 17, 2025
概括
阿尔茨海默病 (AD) 涉及遗传,环境和生活方式因素,包括炎症和氧化应激. 了解这些相互关联的原因对于开发有效的AD治疗和干预措施至关重要.
科学领域:
- 神经科学是一个神经科学.
- 病理生理学 病理生理学
- 遗传学 是一个遗传学.
背景情况:
- 阿尔茨海默病 (AD) 的发病因子是多因素的,涉及粉样β斑块,团和神经退行.
- 研究AD的根本原因对于开发有效的治疗策略至关重要.
研究的目的:
- 审查导致阿尔茨海默病 (AD) 的主要病理生理学.
- 为了分析粉样β斑块的积累,团,以及AD中的神经元损失.
- 确定导致AD发展的关键生物和环境因素.
主要方法:
- 从1999年10月到2025年4月的研究文献综述.
- 搜索的数据库包括PubMed和Scopus.
- 分析了关于阿尔茨海默病 (AD) 病理生理学的190个参考文献.
主要成果:
- 关键因素包括遗传突变,线粒体功能障碍,荷尔蒙失衡,炎症,氧化应激和神经递质缺乏.
- 调节,生物金属失衡 (铜,铁,,) 和血脑屏障的完整性都与此有关.
- 生活方式因素 (酒精,吸烟),血管变化和病原体存在可能导致AD发展.
结论:
- 阿尔茨海默病 (AD) 的发展是由遗传,生化和环境因素的复杂相互作用所塑造的.
- 神经炎症和氧化应激形成一个反循环,加速神经退行.
- 对于AD的研究和治疗,需要综合遗传学,细胞生物学,环境因素和潜在的病原体参与的综合方法.
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K
Amyloid Fibrils
11.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.6K
Coronary Artery Disease II: Pathophysiology
366
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
366


